{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:41:53Z","timestamp":1793036513306,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:00:00Z","timestamp":1792972800000},"content-version":"vor","delay-in-days":111,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hefei Comprehensive National Science Center Institute of Health and Medicine Project"},{"name":"grants from the National Natural Science Foundation of China","id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"USTC Research Funds of the Double First-Class Initiative"},{"name":"Research Funds of Centre for Leading Medicine and Advanced Technologies of IHM"},{"name":"Scientific Research Project Funding of Anhui Provincial Education Department"},{"name":"Joint Fund for Medical Artificial Intelligence"},{"name":"Clinical and Translational Research Project of Anhui Province"},{"name":"Health Research Program of Anhui"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02540-4","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:15:43Z","timestamp":1783404943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Self-Developed IL-6R\u03b1 Nanobody Alleviates Experimental Autoimmune Uveitis by Inhibiting Th1 and Th17 Cells"],"prefix":"10.1007","volume":"49","author":[{"given":"Bochen","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dali","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuewei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouhuan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niannian","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"2540_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13287-019-1372-0","volume":"10","author":"N Li","year":"2019","unstructured":"Li, N., L. Zhao, Y. Wei, V. L. Ea, H. Nian, and R. Wei. 2019. Recent advances of exosomes in immune-mediated eye diseases. Stem Cell Research & Therapy 10:278.","journal-title":"Stem Cell Research & Therapy"},{"key":"2540_CR2","first-page":"76","volume":"13","author":"KW Price","year":"2020","unstructured":"Price, K. W., T. A. Albini, and S. Yeh. 2020. Suprachoroidal injection of triamcinolone- review of a novel treatment for macular edema caused by noninfectious uveitis. US Ophthalmic Rev 13:76\u201379.","journal-title":"US Ophthalmic Rev"},{"key":"2540_CR3","doi-asserted-by":"publisher","first-page":"1267765","DOI":"10.3389\/fphar.2023.1267765","volume":"14","author":"B He","year":"2023","unstructured":"He, B., F. Wang, and L. Qu. 2023. Role of peptide-cell surface interactions in cosmetic peptide application. Frontiers In Pharmacology 14:1267765.","journal-title":"Frontiers In Pharmacology"},{"key":"2540_CR4","doi-asserted-by":"publisher","first-page":"116605","DOI":"10.1016\/j.bcp.2024.116605","volume":"230","author":"X Yu","year":"2024","unstructured":"Yu, X., R. Duan, L. Jiang, T. Wang, Z. Li, B. Zhang, W. Su, and Y. Lin. 2024. Interleukin-6 in non-infectious uveitis: Biology, experimentalevidence and treatment strategies. Biochemical Pharmacology 230:116605.","journal-title":"Biochemical Pharmacology"},{"key":"2540_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.5114\/ceji.2019.89596","volume":"44","author":"JH Jung","year":"2019","unstructured":"Jung, J. H., G. G. Song, J. H. Kim, and S. J. Choi. 2019. The associations between interleukin 10 polymorphisms and susceptibility to autoimmune uveitis - a meta-analysis. Cent Eur J Immunol 44:246\u2013252.","journal-title":"Cent Eur J Immunol"},{"key":"2540_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0923-1811(95)00439-4","volume":"11","author":"Y Yamakawa","year":"1996","unstructured":"Yamakawa, Y., Y. Sugita, T. Nagatani, S. Takahashi, T. Yamakawa, S. Tanaka, S. Nakamura, S. Ohno, H. Sekihara, K. Okuda, and H. Nakajima. 1996. Interleukin-6 (IL-6) in patients with Beh\u00e7et\u2019s disease. Journal Of Dermatological Science 11:189\u2013195.","journal-title":"Journal Of Dermatological Science"},{"key":"2540_CR7","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1167\/iovs.16-19758","volume":"57","author":"AM Abu El-Asrar","year":"2016","unstructured":"Abu El-Asrar, A. M., N. Berghmans, S. A. Al-Obeidan, A. Mousa, G. Opdenakker, J. Van Damme, and S. Struyf. 2016. The cytokine interleukin-6 and the chemokines CCL20 and CXCL13 are novel biomarkers of specific endogenous uveitic entities. Invest Ophthalmol Vis Sci 57:4606\u20134613.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2540_CR8","doi-asserted-by":"publisher","first-page":"587443","DOI":"10.3389\/fimmu.2020.587443","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen, Z., Z. Zhong, W. Zhang, G. Su, and P. Yang. 2020. Integrated analysis of key pathways and drug targets associated with Vogt-Koyanagi-Harada disease. Frontiers In Immunology 11:587443.","journal-title":"Frontiers In Immunology"},{"key":"2540_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/09273948.2019.1704022","volume":"29","author":"A Kumar","year":"2021","unstructured":"Kumar, A., S. P. Sharma, A. Agarwal, V. Gupta, D. Katoch, S. Sehgal, and N. Singh. 2021. Tear IL-6 and IL-10 levels in HLA-B27-associated uveitis and its clinical implications. Ocular Immunology And Inflammation 29:237\u2013243.","journal-title":"Ocular Immunology And Inflammation"},{"key":"2540_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.preteyeres.2016.02.002","volume":"52","author":"L Du","year":"2016","unstructured":"Du, L., A. Kijlstra, and P. Yang. 2016. Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment. Progress In Retinal And Eye Research 52:84\u2013111.","journal-title":"Progress In Retinal And Eye Research"},{"key":"2540_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/APO.0000000000000371","volume":"10","author":"LB Ferreira","year":"2021","unstructured":"Ferreira, L. B., A. J. Smith, and J. R. Smith. 2021. Biologic drugs for the treatment of noninfectious uveitis. Asia Pac J Ophthalmol (Phila) 10:63\u201373.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"2540_CR12","doi-asserted-by":"publisher","first-page":"112993","DOI":"10.1016\/j.ejmech.2020.112993","volume":"210","author":"P Mart\u00edn-Acosta","year":"2021","unstructured":"Mart\u00edn-Acosta, P., and X. Xiao. 2021. PROTACs to address the challenges facing small molecule inhibitors. European Journal Of Medicinal Chemistry 210:112993.","journal-title":"European Journal Of Medicinal Chemistry"},{"key":"2540_CR13","doi-asserted-by":"crossref","unstructured":"Zhang, X., J. Wang, Y. Tan, C. Chen, S. Tang, S. Zhao, Q. Qin, H. Huang, and S. Duan. 2024. Nanobodies in cytokine\u2013mediated immunotherapy and immunoimaging (Review). International Journal of Molecular Medicine 53(2):12.","DOI":"10.3892\/ijmm.2023.5336"},{"key":"2540_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12951-024-02573-7","volume":"22","author":"Y Yang","year":"2024","unstructured":"Yang, Y., F. Li, and L. Du. 2024. Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses. J Nanobiotechnology 22:304.","journal-title":"J Nanobiotechnology"},{"key":"2540_CR15","doi-asserted-by":"crossref","unstructured":"Jin, B. K., S. Odongo, M. Radwanska, and S. Magez. 2023. NANOBODIES\u00ae: A review of diagnostic and therapeutic applications. International Journal of Molecular Sciences 24(6):5994.","DOI":"10.3390\/ijms24065994"},{"key":"2540_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.2174\/1566524015666150731100318","volume":"15","author":"J Chen","year":"2015","unstructured":"Chen, J., H. Qian, R. Horai, C. C. Chan, and R. R. Caspi. 2015. Mouse models of experimental autoimmune uveitis: comparative analysis of adjuvant-induced vs spontaneous models of uveitis. Current Molecular Medicine 15:550\u2013557.","journal-title":"Current Molecular Medicine"},{"key":"2540_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read, R. W., G. N. Holland, N. A. Rao, K. F. Tabbara, S. Ohno, L. Arellanes-Garcia, P. Pivetti-Pezzi, H. H. Tessler, and M. Usui. 2001. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. American Journal Of Ophthalmology 131:647\u2013652.","journal-title":"American Journal Of Ophthalmology"},{"key":"2540_CR18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jamaophthalmol.2018.2664","volume":"136","author":"P Yang","year":"2018","unstructured":"Yang, P., Y. Zhong, L. Du, W. Chi, L. Chen, R. Zhang, M. Zhang, H. Wang, H. Lu, L. Yang, W. Zhuang, Y. Yang, L. Xing, L. Feng, Z. Jiang, X. Zhang, Y. Wang, H. Zhong, L. Jiang, C. Zhao, F. Li, S. Cao, X. Liu, X. Chen, Y. Shi, W. Zhao, and A. Kijlstra. 2018. Development and evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease. JAMA Ophthalmol 136:1025\u20131031.","journal-title":"JAMA Ophthalmol"},{"key":"2540_CR19","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1167\/iovs.15-17280","volume":"56","author":"MJ Mattapallil","year":"2015","unstructured":"Mattapallil, M. J., P. B. Silver, L. M. Cortes, A. J. St Leger, Y. Jittayasothorn, J. L. Kielczewski, J. J. Moon, C. C. Chan, and R. R. Caspi. 2015. Characterization of a new epitope of IRBP that induces moderate to severe uveoretinitis in mice With H-2b haplotype. Invest Ophthalmol Vis Sci 56:5439\u20135449.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2540_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jim.2006.01.022","volume":"312","author":"W Van den Broeck","year":"2006","unstructured":"Van den Broeck, W., A. Derore, and P. Simoens. 2006. Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB\/cAnNCrl mice. Journal Of Immunological Methods 312:12\u201319.","journal-title":"Journal Of Immunological Methods"},{"key":"2540_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/978-1-60761-720-4_22","volume":"900","author":"RK Agarwal","year":"2012","unstructured":"Agarwal, R. K., P. B. Silver, and R. R. Caspi. 2012. Rodent models of experimental autoimmune uveitis. Methods In Molecular Biology 900:443\u2013469.","journal-title":"Methods In Molecular Biology"},{"key":"2540_CR22","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.gendis.2022.09.008","volume":"10","author":"S He","year":"2023","unstructured":"He, S., W. Li, G. Wang, X. Wang, W. Fan, Z. Zhang, N. Li, and S. Hou. 2023. FTO-mediated m6A modification alleviates autoimmune uveitis by regulating microglia phenotypes via the GPC4\/TLR4\/NF-\u03baB signaling axis. Genes Dis 10:2179\u20132193.","journal-title":"Genes Dis"},{"key":"2540_CR23","doi-asserted-by":"publisher","first-page":"e19542","DOI":"10.1371\/journal.pone.0019542","volume":"6","author":"L Tian","year":"2011","unstructured":"Tian, L., P. Yang, B. Lei, J. Shao, C. Wang, Q. Xiang, L. Wei, Z. Peng, and A. Kijlstra. 2011. AAV2-mediated subretinal gene transfer of hIFN-\u03b1 attenuates experimental autoimmune uveoretinitis in mice. PLoS One 6:e19542.","journal-title":"PLoS One"},{"key":"2540_CR24","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang, S., H. Li, L. Zhang, W. Mu, Y. Zhang, T. Chen, J. Wu, H. Tang, S. Zheng, Y. Liu, Y. Wu, X. Luo, Y. Xie, and J. Ren. 2025. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Research 53:D1670\u2013d6.","journal-title":"Nucleic Acids Research"},{"key":"2540_CR25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.autrev.2017.08.002","volume":"16","author":"M Mesquida","year":"2017","unstructured":"Mesquida, M., B. Molins, V. Lloren\u00e7, M. S. de la Maza, and A. Ad\u00e1n. 2017. Targeting interleukin-6 in autoimmune uveitis. Autoimmun Rev 16:1079\u20131089.","journal-title":"Autoimmun Rev"},{"key":"2540_CR26","doi-asserted-by":"crossref","unstructured":"Zong, Y., M. Miyagaki, M. Yang, J. Zhang, Y. Zou, K. Ohno-Matsui, and K. Kamoi. 2024. Ophthalmic use of targeted biologics in the management of intraocular diseases: current and emerging therapies. Antibodies (Basel) 13(4):86.","DOI":"10.3390\/antib13040086"},{"key":"2540_CR27","doi-asserted-by":"publisher","first-page":"18778","DOI":"10.3390\/ijms160818778","volume":"16","author":"S M\u00e9rida","year":"2015","unstructured":"M\u00e9rida, S., E. Palacios, A. Navea, and F. Bosch-Morell. 2015. New immunosuppressive therapies in uveitis treatment. International Journal Of Molecular Sciences 16:18778\u201318795.","journal-title":"International Journal Of Molecular Sciences"},{"key":"2540_CR28","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/eji.201747029","volume":"48","author":"C Lyu","year":"2018","unstructured":"Lyu, C., S. J. Bing, W. S. Wandu, B. Xu, G. Shi, S. J. Hinshaw, M. Lobera, R. R. Caspi, L. Lu, J. Yang, and I. Gery. 2018. TMP778, a selective inhibitor of ROR\u03b3t, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations. European Journal Of Immunology 48:1810\u20131816.","journal-title":"European Journal Of Immunology"},{"key":"2540_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3109\/08830185.2012.747524","volume":"32","author":"JV Forrester","year":"2013","unstructured":"Forrester, J. V., I. P. Klaska, T. Yu, and L. Kuffova. 2013. Uveitis in mouse and man. International Reviews Of Immunology 32:76\u201396.","journal-title":"International Reviews Of Immunology"},{"key":"2540_CR30","doi-asserted-by":"publisher","first-page":"111279","DOI":"10.1016\/j.isci.2024.111279","volume":"27","author":"Z Li","year":"2024","unstructured":"Li, Z., R. Duan, Q. Jiang, J. Liu, J. Chen, L. Jiang, T. Wang, H. Li, Y. Zhang, X. Peng, Z. Huang, L. Zhu, W. Zou, and Y. Lin, W. Su. 2024. Dietary caloric restriction protects experimental autoimmune uveitis by regulating Teff\/Treg balance. iScience 27:111279.","journal-title":"iScience"},{"key":"2540_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1167\/iovs.65.14.33","volume":"65","author":"J Glass","year":"2024","unstructured":"Glass, J., R. Robinson, N. Edupuganti, J. Altman, G. Greenway, T. J. Lee, W. Zhi, A. Sharma, and S. Sharma. 2024. Proteomic alterations in retinal m\u00fcller glial cells lacking Interleukin-6 receptor: a comprehensive analysis. Invest Ophthalmol Vis Sci 65:33.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2540_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S1074-7613(04)00003-2","volume":"20","author":"S Rose-John","year":"2004","unstructured":"Rose-John, S., and M. F. Neurath. 2004. IL-6 trans-signaling: the heat is on. Immunity 20:2\u20134.","journal-title":"Immunity"},{"key":"2540_CR33","doi-asserted-by":"publisher","first-page":"1265835","DOI":"10.3389\/fmed.2023.1265835","volume":"10","author":"B Dou","year":"2023","unstructured":"Dou, B., S. Ren, L. Qiu, X. Zhang, N. Zhang, J. Cai, D. Chen, Q. Zhang, H. Yao, and F. Fan. 2023. Prophylactic use of interleukin 6 monoclonal antibody can reduce CRS response of CAR-T cell therapy. Front Med (Lausanne) 10:1265835.","journal-title":"Front Med (Lausanne)"},{"key":"2540_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ni.3632","volume":"18","author":"S Heink","year":"2017","unstructured":"Heink, S., N. Yogev, C. Garbers, M. Herwerth, L. Aly, C. Gasperi, V. Husterer, A. L. Croxford, K. M\u00f6ller-Hackbarth, H. S. Bartsch, K. Sotlar, S. Krebs, T. Regen, H. Blum, B. Hemmer, T. Misgeld, T. F. Wunderlich, J. Hidalgo, M. Oukka, S. Rose-John, M. Schmidt-Supprian, A. Waisman, and T. Korn. 2017. Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic T(H)17 cells. Nature Immunology 18:74\u201385.","journal-title":"Nature Immunology"},{"key":"2540_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/cts.12849","volume":"14","author":"KV Rogers","year":"2021","unstructured":"Rogers, K. V., S. W. Martin, I. Bhattacharya, R. S. P. Singh, and S. Nayak. 2021. A dynamic quantitative systems pharmacology model of inflammatory bowel disease: Part 1 - model framework. Clinical And Translational Science 14:239\u2013248.","journal-title":"Clinical And Translational Science"},{"key":"2540_CR36","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec, P., T. Korn, and V. K. Kuchroo. 2009. Interleukin-17 and type 17 helper T cells. New England Journal Of Medicine 361:888\u2013898.","journal-title":"New England Journal Of Medicine"},{"key":"2540_CR37","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/eji.201040391","volume":"40","author":"A Kimura","year":"2010","unstructured":"Kimura, A., and T. Kishimoto. 2010. IL-6: regulator of Treg\/Th17 balance. European Journal Of Immunology 40:1830\u20131835.","journal-title":"European Journal Of Immunology"},{"key":"2540_CR38","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1074-7613(00)00078-9","volume":"13","author":"S Diehl","year":"2000","unstructured":"Diehl, S., J. Anguita, A. Hoffmeyer, T. Zapton, J. N. Ihle, E. Fikrig, and M. Rinc\u00f3n. 2000. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13:805\u2013815.","journal-title":"Immunity"},{"key":"2540_CR39","doi-asserted-by":"publisher","first-page":"6683411","DOI":"10.1155\/2021\/6683411","volume":"2021","author":"S Li","year":"2021","unstructured":"Li, S., F. Liu, K. Zhang, Y. Tong, and X. Liu. 2021. Research progress on the mechanism of natural product ingredients in the treatment of uveitis. Journal of Immunology Research 2021:6683411.","journal-title":"Journal of Immunology Research"},{"key":"2540_CR40","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1167\/iovs.10-6272","volume":"52","author":"H Haruta","year":"2011","unstructured":"Haruta, H., N. Ohguro, M. Fujimoto, S. Hohki, F. Terabe, S. Serada, S. Nomura, K. Nishida, T. Kishimoto, and T. Naka. 2011. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 52:3264\u20133271.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2540_CR41","first-page":"77","volume":"32","author":"G Guggino","year":"2014","unstructured":"Guggino, G., A. R. Giardina, S. Raimondo, G. Giardina, G. Sireci, F. Dieli, M. Peralta, R. Alessandro, G. Triolo, and F. Ciccia. 2014. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion. Clinical And Experimental Rheumatology 32:77\u201381.","journal-title":"Clinical And Experimental Rheumatology"},{"key":"2540_CR42","doi-asserted-by":"publisher","first-page":"106649","DOI":"10.1016\/j.intimp.2020.106649","volume":"85","author":"L Peng","year":"2020","unstructured":"Peng, L., J. Zhong, Y. Xiao, B. Wang, S. Li, Y. Deng, D. He, and J. Yuan. 2020. Therapeutic effects of an anti-IL-6 antibody in fungal keratitis: Macrophage inhibition and T cell subset regulation. International Immunopharmacology 85:106649.","journal-title":"International Immunopharmacology"},{"key":"2540_CR43","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/art.42273","volume":"74","author":"T Takeuchi","year":"2022","unstructured":"Takeuchi, T., M. Kawanishi, M. Nakanishi, H. Yamasaki, and Y. Tanaka. 2022. Phase II\/III results of a trial of anti-tumor necrosis factor multivalent nanobody compound ozoralizumab in patients with rheumatoid arthritis. Arthritis Rheumatol 74:1776\u20131785.","journal-title":"Arthritis Rheumatol"},{"key":"2540_CR44","doi-asserted-by":"crossref","unstructured":"Mbanefo, E. C., A. Seifert, M. K. Yadav, C. R. Yu, V. Nagarajan, A. Parihar, S. Singh, and C. E. Egwuagu. 2024. A camelid-derived STAT-specific nanobody inhibits neuroinflammation and ameliorates Experimental Autoimmune Encephalomyelitis (EAE). Cells 13(12):1042.","DOI":"10.3390\/cells13121042"},{"key":"2540_CR45","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1111\/bph.15457","volume":"178","author":"C Liu","year":"2021","unstructured":"Liu, C., F. Zhou, Z. Yan, L. Shen, X. Zhang, F. He, H. Wang, X. Lu, K. Yu, Y. Zhao, and D. Zhu. 2021. Discovery of a novel, potent and selective small-molecule inhibitor of PD-1\/PD-L1 interaction with robust in vivo anti-tumour efficacy. British Journal Of Pharmacology 178:2651\u20132670.","journal-title":"British Journal Of Pharmacology"},{"key":"2540_CR46","doi-asserted-by":"crossref","unstructured":"Xue, A., and S. Fan. 2022. Matrices and affinity ligands for antibody purification and corresponding applications in radiotherapy. Biomolecules 12(6):821.","DOI":"10.3390\/biom12060821"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02540-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02540-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02540-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:05:54Z","timestamp":1793034354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02540-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2540"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02540-4","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Medical Ethics Committee of the First Affiliated Hospital of the University of Science and Technology of China agreed to do this study (No. 2025KY110). All procedures were conducted in accordance with the Declaration of Helsinki. All participants signed an informed consent form at the start of the study. The animal experiments were approved by the Ethics Committee of the First Affiliated Hospital of the University of Science and Technology of China.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Some of the co-authors are inventors of the nanobody-related patent (No. US 12,291,573 B2), which constitutes a direct competing interest. The remaining authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"207"}}